Effect of Dual-Task Training on Pediatric Oncology Patients

Cancer Clinical Trial

Official title:

Evaluation of the Effect of Dual-Task Training on Muscle Strength, Balance, and Gait in Pediatric Oncology Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05118464
• Other study ID #: 2020/387
• Status: Recruiting
• Phase: N/A
• Start date: September 15, 2021
• Est. completion date: September 15, 2023

Study information

• Verified date: November 2021
• Source: Afyonkarahisar Health Sciences University
• Contact: EMEL TASVURAN HORATA, PhD
• Phone: +905547759663
• Email: ethorata[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Description:

With the increase in the incidence of cancer, the number of children who survived cancer is also increasing. Most studies on cancer survivors show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, motor, and cognitive skills. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait. This study is planned to be the first study in which dual-task training is applied in children with cancer.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 21
• Est. completion date: September 15, 2023
• Est. primary completion date: September 15, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Years to 18 Years

Eligibility

Inclusion Criteria:

• Diagnosed with pediatric cancer and inpatient and outpatient treatment in Hematology-Oncology Clinics for treatment,
• Able to walk alone without any walking aid,
• Children aged 6-18 will be included

Exclusion Criteria:

• Staying in an isolated room or at risk of infection (neutropenic, etc.),
• Any orthopedic or neurological disorder that may prevent walking;
• Having any mental disability that will prevent performing a cognitive task,
• Individuals with malignant hypertension or unstable heart disease (eg, congestive heart failure) will not be included in the study.

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Dual-task training
Dual-task training includes simultaneous execution of motor and cognitive tasks. The motor tasks in this study will be walking, going up and downstairs, turning, throwing, and holding a ball. Cognitive tasks will be an n-back test, verbal fluency, remembering sequences of numbers, and performing simple summing.

Locations

Country	Name	City	State
Turkey	Emel Tasvuran Horata	Afyonkarahisar

Sponsors (1)

Lead Sponsor	Collaborator
Afyonkarahisar Health Sciences University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	gait speed	Gait speed is the time one takes to walk a specified distance on level surfaces over a short distance. It will be recorded in m/s.	600 seconds
Primary	balance	Balance is evaluated with Timed-up and Go Test. The time elapsed during the test is recorded in seconds.	300 seconds
Primary	Muscle strength	Isometric muscle strength will be evaluated with a hand-held dynamometer. It will be recorded in kg.	600 seconds